Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEMOS ALL 0105 Intensification Therapy of Mature B-ALL, Burkitt and High-Grade Non-Hodgkin Lymphoma in Adults
2006-006154-97Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- May 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rituximab in acute lymphoblastic leukemia (ALL), Burkitt lymphoma (BL), B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma and 1 more, sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Remission improvement. Started May 2007; status: completed.
02
Drugs
rituximab
03
Conditions
acute lymphoblastic leukemia (ALL)Burkitt lymphoma (BL)B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphomanon-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on 2006-006154-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006154-97.